UK markets close in 7 hours 44 minutes

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
234.29-1.30 (-0.55%)
At close: 04:00PM EDT
234.00 -0.29 (-0.12%)
After hours: 06:10PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts20202424
Avg. Estimate-1.09-1.05-3.55-1.62
Low estimate-1.57-1.69-5.68-3.78
High estimate-0.36-0.31-1.072.43
Year ago EPS-2.211.15-3.52-3.55
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts24213029
Avg. Estimate446.06M460.01M1.88B2.33B
Low estimate415M441M1.73B1.48B
High estimate492M495.5M2B3.02B
Year ago sales318.75M750.53M1.83B1.88B
Sales growth (year/est)39.90%-38.70%2.70%24.20%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.37-1.34-1.32-1.18
Actual EPS-2.211.15-1.1-0.52
Difference-0.842.490.220.66
Surprise %-61.30%185.80%16.70%55.90%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.09-1.05-3.55-1.62
7 days ago-1.09-1.05-3.55-1.63
30 days ago-1.11-1.06-3.47-1.86
60 days ago-1.11-1.06-3.6-1.87
90 days ago-1.04-1.1-4.11-1.76
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1N/A22
Up last 30 days4366
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A1N/AN/A
Growth estimatesALNYIndustrySector(s)S&P 500
Current qtr.50.70%N/AN/AN/A
Next qtr.-191.30%N/AN/AN/A
Current year-0.90%N/AN/AN/A
Next year54.40%N/AN/AN/A
Next 5 years (per annum)-177.50%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A